Corteva (CTVA) Projected to Release Quarterly Earnings on Thursday

Corteva (NYSE:CTVA) will likely be issuing its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect the company to announce earnings of $2.23 per share and revenue of $6.5930 billion for the quarter. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Investors can find conference call details on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Friday, July 31, 2026 at 9:00 AM ET.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the firm earned $1.13 EPS. The firm’s revenue was up 11.0% on a year-over-year basis. On average, analysts expect Corteva to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Corteva Trading Up 1.9%

Shares of NYSE:CTVA opened at $88.56 on Thursday. Corteva has a 52-week low of $60.53 and a 52-week high of $88.57. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market cap of $59.23 billion, a price-to-earnings ratio of 52.09, a PEG ratio of 2.64 and a beta of 0.56. The business has a 50-day moving average price of $81.13 and a 200-day moving average price of $78.69.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s payout ratio is 42.35%.

Institutional Investors Weigh In On Corteva

Institutional investors have recently made changes to their positions in the stock. JPL Wealth Management LLC acquired a new position in Corteva during the 3rd quarter worth $25,000. Garton & Associates Financial Advisors LLC acquired a new stake in Corteva in the 4th quarter valued at about $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva in the 4th quarter valued at about $28,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of Corteva during the third quarter worth approximately $33,000. Finally, Binnacle Investments Inc increased its stake in shares of Corteva by 54.7% during the second quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after buying an additional 181 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Rothschild & Co Redburn upped their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Argus boosted their price target on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, March 31st. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, May 7th. UBS Group dropped their price objective on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 9th. Finally, The Goldman Sachs Group lifted their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, April 14th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $89.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.